Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

208.61B

Market cap208.61B

Price-Earnings ratio

11.51

Price-Earnings ratio11.51

Dividend yield

2.61%

Dividend yield2.61%

Average volume

17.18M

Average volume17.18M

High today

$46.70

High today$46.70

Low today

$45.57

Low today$45.57

Open price

$45.87

Open price$45.87

Volume

9.56M

Volume9.56M

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

CNBC 6h

Novo Nordisk CEO Mike Doustdar sits down with Jim Cramer - CNBC

...

Simply Wall St 10h

Novo Nordisk Stock Still Looks Cheap On Earnings But Faces Growth Doubts

Novo Nordisk stock has pulled back sharply over the last three years, yet the company still screens as attractively valued on several checks. Recent news on obe...

Nasdaq 1d

Novo Nordisk Stock: Buy or Sell?

The company reported quarterly financial results, which have implications for shareholders. Where to invest $1,000 right now? Our analyst team just revealed wh...

Analyst ratings

57%

of 37 ratings

Buy

35.1%

Hold

56.8%

Sell

8.1%

More NVO News

Nasdaq 1d

Better Buy: Eli Lilly vs. Novo Nordisk

Key Points Eli Lilly has a stronger GLP-1 portfolio and pipeline than Novo Nordisk. Eli Lilly also has a better lineup outside the diabetes and weight-loss ar...

TipRanks 2d

Novo Nordisk’s New Obesity Metabolism Trial: What Investors Should Watch

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident i...

Nasdaq 2d

NVO Crosses Above Average Analyst Target

In recent trading, shares of Novo-Nordisk AS (Symbol: NVO) have crossed above the average analyst 12-month target price of $47.48, changing hands for $47.73/sha...

The Motley Fool 2d

Why Eli Lilly Topped the Market Today

Eli Lilly (LLY +3.90%) had a fine start to the trading week. On Monday, its stock rose by almost 4% on news that a key European regulator had approved one of it...

TipRanks 3d

Novo Nordisk Expands Treasury Position as 2026 Share Buyback Nears DKK 8 Billion

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Simply Wall St 6d

Novo Nordisk Faces A Fair Value Debate, Is It Still 55% Undervalued?

Novo Nordisk (NYSE:NVO) has drawn fresh attention after recent share price moves, with the stock closing at US$45.97. Investors are weighing this level against...

TipRanks 7d

Retail Investors Send in Sick Note for HIMS Stock Ahead of Q2 Earnings

Retail investors are feeling less healthy about the prospects of Hims & Hers (HIMS) as it gets set to report Q2 earnings next week – August 10th. Unlock powerf...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.